Riskpilot← Back to searchSign inGet full accessLäkarhuset Kungsbacka AB
ABActiveOrg 5591315907Varlabergsvägen 25 2trGeneral medical practice activities · NACE 8621Est. 20175 employees
Revenue 2024
SEK 8,5M
+29% vs 2023
EBITDA margin
25.6%
+114% vs 2023
Equity ratio
61.6%
Financial strength
Net profit 2024
SEK 1,2M
+124% vs 2023
| Revenue | SEK 8,5M | +29% |
| EBITDA | SEK 2,2M | +114% |
| Net profit | SEK 1,2M | +124% |
| Total assets | SEK 6M | +27% |
| Equity | SEK 3,7M | +28% |
| Employees | 5 | — |
Legal name
Läkarhuset Kungsbacka AB
Org number
5591315907
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 oktober 2017
Share capital
SEK 50 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Aktiebolaget skall bedriva medicinsk verksamhet inom sjukvård, företagshälsovård och estetik, samt med detta förenlig verksamhet.
Address
Varlabergsvägen 25 2tr
Email
info@lakarhusetkungsbacka.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 368 | 6 598 | 5 841 | 6 595 | 8 523 |
| Staff expenses | — | — | — | −3 391 | −3 720 |
| EBITDA | 231 | 1 273 | 1 223 | 1 017 | 2 180 |
| Depreciation & amort. | −217 | −332 | −318 | −277 | −233 |
| EBIT | 14 | 941 | 905 | 740 | 1 947 |
| Net financials | −25 | −19 | −16 | −4 | 41 |
| Profit before tax | 3 | 692 | 661 | 665 | 1 481 |
| Tax | −3 | −146 | −141 | −144 | −314 |
| Net profit | 0 | 546 | 520 | 521 | 1 167 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 104 | 4 070 | 4 715 | 4 715 | 5 995 |
| Equity | 1 736 | 2 208 | 2 368 | 2 889 | 3 696 |
| Long-term debt | 533 | 433 | 272 | 0 | — |
| Short-term debt | 651 | 1 015 | 1 433 | 1 113 | 1 079 |
| Total debt | 1 184 | 1 448 | 1 705 | 1 113 | 1 079 |
EBITDA margin
25.6%
This company
15.8%
Market median
+62% vs market
20202024
Equity ratio
61.6%
This company
38.2%
Market median
+61% vs market
20202024
Return on equity
31.6%
This company
18.4%
Market median
+72% vs market
20202024
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
20202024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2025 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Chairman | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkarhuset Kungsbacka AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Oscar Erik Wilhelm Silfversparre | Audit | 0 companies |
| Sarah Fatima Syed | Board of Directors | 0 companies |
| Nils Lars Johan Magnusson | Chairman | 0 companies |
| Sara Parsifar | Chairman | 0 companies |
| Tim Dexenius Parsifar | Deputy Board Member | 0 companies |